Barclays Maintains Overweight on IQVIA Holdings, Raises Price Target to $300

10/7/2026
Impact: 75
Healthcare

Barclays analyst Luke Sergott has maintained an Overweight rating on IQVIA Holdings (NYSE: IQV) and raised the price target from $275 to $300. This adjustment reflects a positive outlook on the company's performance in the market.

AI summary, not financial advice

Share: